InChI=1S/C53H89N3O39/c1- 12- 26(66) 34(74) 39(79) 51(83- 12) 92- 42- 25(56- 15(4) 64) 46(80) 84- 21(9- 61) 41(42) 91- 48- 24(55- 14(3) 63) 33(73) 40(20(8- 60) 88- 48) 90- 53- 45(95- 50- 37(77) 27(67) 16(65) 10- 81- 50) 43(31(71) 22(89- 53) 11- 82- 49- 38(78) 35(75) 29(69) 18(6- 58) 86- 49) 93- 52- 44(36(76) 30(70) 19(7- 59) 87- 52) 94- 47- 23(54- 13(2) 62) 32(72) 28(68) 17(5- 57) 85- 47/h12,16- 53,57- 61,65- 80H,5- 11H2,1- 4H3,(H,54,62) (H,55,63) (H,56,64) /t12- ,16+,17+,18+,19+,20+,21+,22+,23+,24+,25+,26+,27- ,28+,29+,30+,31+,32+,33+,34+,35- ,36- ,37+,38- ,39- ,40+,41+,42+,43- ,44- ,45- ,46?,47- ,48- ,49- ,50- ,51- ,52+,53- /m0/s1 |
UFMPJVMIIBFDSB-OMFVTQMHSA-N |
C[C@@H] 1O[C@@H] (O[C@@H] 2[C@@H] (NC(C) =O) C(O) O[C@H] (CO) [C@H] 2O[C@@H] 2O[C@H] (CO) [C@@H] (O[C@@H] 3O[C@H] (CO[C@H] 4O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@@H] 4O) [C@@H] (O) [C@H] (O[C@H] 4O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@@H] 4O[C@@H] 4O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@H] 4NC(C) =O) [C@@H] 3O[C@@H] 3OC[C@@H] (O) [C@H] (O) [C@H] 3O) [C@H] (O) [C@H] 2NC(C) =O) [C@@H] (O) [C@H] (O) [C@@H] 1O |
|
Outgoing
|
α- L- Fucp- (1→3)- {β- D- GlcpNAc- (1→2)- α- D- Manp- (1→3)- [α- D- Manp- (1→6)]- [β- D- Xylp- (1→2)]- β- D- Manp- (1→4)- β- D- GlcpNAc- (1→4)}- D- GlcpNAc
(CHEBI:152651)
is a
amino octasaccharide
(CHEBI:71060)
α- L- Fucp- (1→3)- {β- D- GlcpNAc- (1→2)- α- D- Manp- (1→3)- [α- D- Manp- (1→6)]- [β- D- Xylp- (1→2)]- β- D- Manp- (1→4)- β- D- GlcpNAc- (1→4)}- D- GlcpNAc
(CHEBI:152651)
is a
amino sugar
(CHEBI:28963)
α- L- Fucp- (1→3)- {β- D- GlcpNAc- (1→2)- α- D- Manp- (1→3)- [α- D- Manp- (1→6)]- [β- D- Xylp- (1→2)]- β- D- Manp- (1→4)- β- D- GlcpNAc- (1→4)}- D- GlcpNAc
(CHEBI:152651)
is a
glucosamine oligosaccharide
(CHEBI:22485)
|
|
Incoming
|
α-L-Fucp-(1→3)-{β-D-GlcpNAc-(1→2)-α-D-Manp-(1→3)-[α-D-Manp-(1→6)]-[β-D-Xylp-(1→2)]-β-D-Manp-(1→4)-β-D-GlcpNAc-(1→4)}-β-D-GlcpNAc
(CHEBI:146812)
is a
α- L- Fucp- (1→3)- {β- D- GlcpNAc- (1→2)- α- D- Manp- (1→3)- [α- D- Manp- (1→6)]- [β- D- Xylp- (1→2)]- β- D- Manp- (1→4)- β- D- GlcpNAc- (1→4)}- D- GlcpNAc
(CHEBI:152651)
|
2- acetamido- 2- deoxy- β- D- glucopyranosyl- (1→2)- α- D- mannopyranosyl- (1→3)- [α- D- mannopyranosyl- (1→6)]- [β- D- xylopyranosyl- (1→2)]- β- D- mannopyranosyl- (1→4)- 2- acetamido- 2- deoxy- β- D- glucopyranosyl- (1→4)- [α- L- fucopyranosyl- (1→3)]- 2- acetamido- 2- deoxy- D- glucopyranose
|
2- acetamido- 2- deoxy- beta- D- gluco- hexopyranosyl- (1→2)- alpha- D- manno- hexopyranosyl- (1→3)- [beta- D- xylo- pentopyranosyl- (1→2)][alpha- D- manno- hexopyranosyl- (1→6)]- beta- D- manno- hexopyranosyl- (1→4)- 2- acetamido- 2- deoxy- beta- D- gluco- hexopyranosyl- (1→4)- [6- deoxy- alpha- L- galacto- hexopyranosyl- (1→3)]- 2- acetamido- 2- deoxy- D- gluco- hexopyranose
|
SUBMITTER
|
GlcNAc(b1-2)Man(a1-3)[Xyl(b1-2)][Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]GlcNAc
|
SUBMITTER
|
GlcNAcβ1- 2Manα1- 3(Manα1- 6)(Xylβ1- 2)Manβ1- 4GlcNAcβ1- 4(Fucα1- 3)GlcNAc
|
IUPAC
|
N- [(2S,3R,4R,5S,6R)- 2- [(2R,3S,4S,5S,6R)- 2- [(2S,3S,4S,5R,6R)- 2- [(2R,3S,4R,5R,6S)- 5- Acetamido- 6- [(2R,3S,4R,5R)- 5- acetamido- 6- hydroxy- 2- (hydroxymethyl)- 4- [(2S,3S,4R,5S,6S)- 3,4,5- trihydroxy- 6- methyloxan- 2- yl]oxyoxan- 3- yl]oxy- 4- hydroxy- 2- (hydroxymethyl)oxan- 3- yl]oxy- 5- hydroxy- 6- [[(2S,3S,4S,5S,6R)- 3,4,5- trihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxymethyl]- 3- [(2S,3R,4S,5R)- 3,4,5- trihydroxyoxan- 2- yl]oxyoxan- 4- yl]oxy- 4,5- dihydroxy- 6- (hydroxymethyl)oxan- 3- yl]oxy- 4,5- dihydroxy- 6- (hydroxymethyl)oxan- 3- yl]acetamide
|
ChEBI
|
N- acetyl- β- D- glucosaminyl- (1→2)- α- D- mannosyl- (1→3)- [α- D- mannosyl- (1→6)]- [β- D- xylosyl- (1→2)]- β- D- mannosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→4)- [α- L- fucosyl- (1→3)]- N- acetyl- β- D- glucosamine
|
ChEBI
|
WURCS=2.0/6,8,7/[a2122h- 1x_1- 5_2*NCC/3=O][a1221m- 1a_1- 5][a2122h- 1b_1- 5_2*NCC/3=O][a1122h- 1b_1- 5][a212h- 1b_1- 5][a1122h- 1a_1- 5]/1- 2- 3- 4- 5- 6- 3- 6/a3- b1_a4- c1_c4- d1_d2- e1_d3- f1_d6- h1_f2- g1
|
SUBMITTER
|
32568414
|
PubMed citation
|
Europe PMC
|
|